These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
359 related items for PubMed ID: 19882053
1. Nucleic acid amplification technology for hepatitis B virus, and its role in blood donation screening in blood banks. Bamaga MS, Azahar EI, Al-Ghamdi AK, Alenzi FQ, Farahat FM. Saudi Med J; 2009 Nov; 30(11):1416-21. PubMed ID: 19882053 [Abstract] [Full Text] [Related]
2. Nucleic acid amplification technology screening for hepatitis C virus and human immunodeficiency virus for blood donations. Bamaga MS, Bokhari FF, Aboud AM, Al-Malki M, Alenzi FQ. Saudi Med J; 2006 Jun; 27(6):781-7. PubMed ID: 16758035 [Abstract] [Full Text] [Related]
3. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy. Kuhns MC, Kleinman SH, McNamara AL, Rawal B, Glynn S, Busch MP, REDS Study Group. Transfusion; 2004 Sep; 44(9):1332-9. PubMed ID: 15318857 [Abstract] [Full Text] [Related]
4. Hepatitis B virus (HBV) DNA screening of blood donations in minipools with the COBAS AmpliScreen HBV test. Kleinman SH, Strong DM, Tegtmeier GG, Holland PV, Gorlin JB, Cousins C, Chiacchierini RP, Pietrelli LA. Transfusion; 2005 Aug; 45(8):1247-57. PubMed ID: 16078909 [Abstract] [Full Text] [Related]
5. Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value? Stramer SL, Zou S, Notari EP, Foster GA, Krysztof DE, Musavi F, Dodd RY. Transfusion; 2012 Feb; 52(2):440-6. PubMed ID: 21810101 [Abstract] [Full Text] [Related]
6. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus. Li L, Chen PJ, Chen MH, Chak KF, Lin KS, Tsai SJ. Transfusion; 2008 Jun; 48(6):1198-206. PubMed ID: 18422856 [Abstract] [Full Text] [Related]
7. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors? Busch MP. Transfus Clin Biol; 2004 Feb; 11(1):26-32. PubMed ID: 14980546 [Abstract] [Full Text] [Related]
8. Anti-HBc screening of blood donors: a comparison of nine anti-HBc tests. Schmidt M, Nübling CM, Scheiblauer H, Chudy M, Walch LA, Seifried E, Roth WK, Hourfar MK. Vox Sang; 2006 Oct; 91(3):237-43. PubMed ID: 16958836 [Abstract] [Full Text] [Related]
9. Donor screening for hepatitis B virus infection in a cell and tissue bank. Solves P, Mirabet V, Alvarez M, Vila E, Quiles F, Villalba JV, Montoro JA, Soler MA, Roig RJ. Transpl Infect Dis; 2008 Dec; 10(6):391-5. PubMed ID: 18665905 [Abstract] [Full Text] [Related]
10. Performance of an algorithm for the reentry of volunteer blood donors deferred due to false-positive test results for antibody to hepatitis B core antigen. Katz L, Strong DM, Tegtmeier G, Stramer S. Transfusion; 2008 Nov; 48(11):2315-22. PubMed ID: 18647367 [Abstract] [Full Text] [Related]
11. Sensitivity of hepatitis B virus DNA transcription-mediated amplification testing in hepatitis B surface antigen-positive blood donations. Bouchardeau F, Girault A, Razer A, Servant-Delmas A, Mercier M, Laperche S. Transfusion; 2006 Dec; 46(12):2047-52. PubMed ID: 17176315 [Abstract] [Full Text] [Related]
12. Hepatitis B virus DNA-positive, hepatitis B surface antigen-negative blood donations intercepted by anti-hepatitis B core antigen testing: the Canadian Blood Services experience. O'Brien SF, Fearon MA, Yi QL, Fan W, Scalia V, Muntz IR, Vamvakas EC. Transfusion; 2007 Oct; 47(10):1809-15. PubMed ID: 17880605 [Abstract] [Full Text] [Related]
13. [Study about seroconversion of HBV NAT screening-positive crowd from blood donors]. Wang DW, Wang TB, Liu FP, Shi LL. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Apr; 22(2):127-9. PubMed ID: 18574536 [Abstract] [Full Text] [Related]
14. Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program. Satake M, Taira R, Yugi H, Hino S, Kanemitsu K, Ikeda H, Tadokoro K. Transfusion; 2007 Jul; 47(7):1197-205. PubMed ID: 17581154 [Abstract] [Full Text] [Related]
16. Two HBV DNA+/HBsAg- blood donors identified by HBV NAT in Shenzhen, China. Shang G, Yan Y, Yang B, Shao C, Wang F, Li Q, Seed CR. Transfus Apher Sci; 2009 Aug; 41(1):3-7. PubMed ID: 19487161 [Abstract] [Full Text] [Related]
17. Epidemiology of antibody to hepatitis B core antigen screening among blood donors in Eastern Saudi Arabia. Need to replace the test by HBV DNA testing. Panhotra BR, Al-Bahrani A, Ul-Hassan Z. Saudi Med J; 2005 Feb; 26(2):270-3. PubMed ID: 15770304 [Abstract] [Full Text] [Related]
18. Efficacy of hepatitis B virus (HBV) DNA screening and characterization of acute and occult HBV infections among blood donors from Madrid, Spain. González R, Torres P, Castro E, Barbolla L, Candotti D, Koppelman M, Zaaijer HL, Lelie N, Allain JP, Echevarría JM. Transfusion; 2010 Jan; 50(1):221-30. PubMed ID: 19682332 [Abstract] [Full Text] [Related]
19. Characterization of HBV DNA+/HBsAg- blood donors in Poland identified by triplex NAT. Brojer E, Grabarczyk P, Liszewski G, Mikulska M, Allain JP, Letowska M, Polish Blood Transfusion Service Viral Study Group. Hepatology; 2006 Dec; 44(6):1666-74. PubMed ID: 17133474 [Abstract] [Full Text] [Related]